TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
benzinga_article·- U.S. stocks experienced a decline on Wednesday, while several specific companies recorded significant share price increases. - TriSalus Life Sciences shares rose 5.8% to $ 5.22 following FDA 510(k) clearance for TriNav Advance. - Other notable gainers included Lakefront Biotherapeutics, which gained 6.8% to $ 32.24 after an analyst upgrade, and Moderna, which rose 4.4% to $ 190.59 on upcoming congress presentations.Maze Therapeutics Reiterated Buy as APOL1 Opportunity Expands; $64 Price Target Maintained
Tip Ranks·- Truist Financial analyst Danielle Brill reaffirmed a buy rating on Maze Therapeutics with a price target of 64.00 dollars. - The rating is driven by the expanding market opportunity for APOL1 inhibitors in AMKD, potentially exceeding 100,000 patients and supporting a multi-billion dollar market. - Vertex Pharmaceuticals' positive Phase 2 clinical data and potential liver safety differentiation for Maze's asset MZE829 further reinforce this favorable outlook.On Holding, Viking Therapeutics, Shopify And Other Big Stocks Moving Higher On Tuesday
benzinga_article·- U.S. stocks traded higher on Tuesday, with major companies experiencing significant gains driven by corporate updates and market analyses. - On Holding shares jumped 13 % following strong sales guidance and a 1 billion dollar buyback program, while Viking Therapeutics surged 35.6 % on positive study results. - Other notable movers included Shopify, which rose 8.6 % after announcing expanded AI shopping collaborations with Meta, and several firms lifted by upgraded analyst ratings.